A detailed history of Daiwa Securities Group Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 117 shares of MEDP stock, worth $39,176. This represents 0.0% of its overall portfolio holdings.

Number of Shares
117
Previous 1,577 92.58%
Holding current value
$39,176
Previous $649,000 93.99%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$320.58 - $457.29 $468,046 - $667,643
-1,460 Reduced 92.58%
117 $39,000
Q2 2024

Aug 07, 2024

SELL
$372.0 - $424.34 $44,268 - $50,496
-119 Reduced 7.02%
1,577 $649,000
Q1 2024

May 02, 2024

BUY
$284.87 - $413.31 $384,859 - $558,381
1,351 Added 391.59%
1,696 $686,000
Q4 2023

Jan 31, 2024

BUY
$227.52 - $312.68 $53,467 - $73,479
235 Added 213.64%
345 $105,000
Q2 2023

Jul 31, 2023

SELL
$187.26 - $240.17 $2,808 - $3,602
-15 Reduced 12.0%
110 $26,000
Q2 2022

Aug 09, 2022

BUY
$130.2 - $168.03 $2,604 - $3,360
20 Added 19.05%
125 $19,000
Q4 2021

Feb 03, 2022

SELL
$182.74 - $227.9 $3,289 - $4,102
-18 Reduced 14.63%
105 $23,000
Q3 2021

Nov 05, 2021

BUY
$170.18 - $198.21 $8,849 - $10,306
52 Added 73.24%
123 $23,000
Q1 2021

May 03, 2021

BUY
$132.02 - $168.26 $528 - $673
4 Added 5.97%
71 $12,000
Q4 2020

Feb 04, 2021

SELL
$109.38 - $149.19 $14,875 - $20,289
-136 Reduced 67.0%
67 $9,000
Q4 2019

Jan 31, 2020

SELL
$70.08 - $84.64 $1,681 - $2,031
-24 Reduced 10.57%
203 $17,000
Q1 2019

Apr 26, 2019

BUY
$49.38 - $70.58 $938 - $1,341
19 Added 9.13%
227 $13,000
Q1 2018

May 02, 2018

BUY
$32.03 - $39.05 $6,662 - $8,122
208 New
208 $7,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.